Related Experiment Video
Updated: Aug 14, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Frizzled receptors in melanomagenesis: From molecular interactions to target identification
Sheikh A Umar1, Bo Dong1, Minakshi Nihal2
1Department of Dermatology, University of Wisconsin-Madison, Madison, WI, United States.
Abstract:
Frizzled (FZD) proteins are receptors for the WNT family ligands. Inherited human diseases and genetic experiments using knockout mice have revealed a central role of FZDs in multiple aspects of embryonic development and tissue homeostasis. Misregulated FZD signaling has also been found in many cancers. Recent studies on three out of the ten mammalian FZDs in melanoma have shown that they promote tumor cell proliferation and invasion, via the activation of the canonical WNT/β-catenin or non-canonical PCP signaling pathway. In this concise review, we summarize our current knowledge of individual FZDs in melanoma, discuss the involvement of both the canonical and non-canonical pathways, and describe ongoing efforts to target the FZD receptors for melanoma treatment.
Insights
Frizzled (FZD) receptors are key in development and cancer. In melanoma, specific FZDs drive tumor growth and spread through WNT pathways, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Developmental Biology
Background:
- Frizzled (FZD) proteins act as WNT ligand receptors.
- FZDs are crucial for embryonic development and tissue maintenance.
- Dysregulated FZD signaling is implicated in various cancers, including melanoma.
Purpose of the Study:
- To review the role of individual FZDs in melanoma.
- To discuss the involvement of canonical and non-canonical WNT pathways in melanoma.
- To highlight therapeutic strategies targeting FZD receptors for melanoma treatment.
Main Methods:
- Literature review of recent studies on FZDs in melanoma.
- Analysis of FZD involvement in WNT/β-catenin and PCP signaling.
- Examination of current therapeutic approaches targeting FZD receptors.
Main Results:
- Three mammalian FZDs are implicated in promoting melanoma cell proliferation and invasion.
- Activation of both canonical WNT/β-catenin and non-canonical PCP pathways by FZDs contributes to melanoma progression.
- Targeting FZD receptors presents a promising avenue for melanoma therapy.
Conclusions:
- Individual FZDs play significant roles in melanoma pathogenesis.
- Both canonical and non-canonical WNT signaling pathways mediated by FZDs are critical in melanoma.
- Developing FZD-targeting therapies holds potential for improving melanoma treatment outcomes.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation

